General discussion, page-2669

First 2669 Last

Share
Profile

Follow
dalts66

4,367 Posts.

2036

13/11/20

17:30

Post #: 48862220
Share

Originally posted by Exalted: ↑

Thanks Dalts. Always the voice of reason.

This is because IHL does have strong buying support with the likes of Canary, Poswell and even our own Chaya on board and buying.
This counteracts the major seller(s) that has been putting strong selling pressure on the stock. Like a tug of war.
Eventually though, this seller(s) will run out of ammo and regretfully for them because we will run after they have blown their load.
Then we can run hard like Andres said about 3DA, MM has said about 3DP, Chaya about ADN etc. It's not rocket science.

I know what other share you're talking about and I think you guys have only one major supporter, forgot his name though. Speaks to the strength of IHL that we have so much powerful buying power to counteract the shenanigans of strong selling pressure.

And again, stating what is happening is not downramping totally agreed.
I hope my opinion is actually helpful to punters that can clearly see the SP being held down and are wondering why.

Because if no one had any opinions, doesn't it sound fishy just to hear accumulation, Canary is buying etc and wondering why the stock is being suppressed? If I didn't believe that there was selling pressure coming through recently I wouldn't actually believe what I was hearing.

With this view it makes perfect sense why the SP is acting the way it is.

Expand

You picked it like a nose E. Well done. Once again that other share mirrored IHL today. I do wonder if it was the same seller.

IHL Price at posting: 9.3¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

There are more pages in this discussion • 17,770 more messages in this thread...

First 2669 Last

Add IHL (ASX) to my watchlist

General discussion, page-2669

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Featured News